Skip to content
LIFEPharma
-
LIFEPharma launches US27.2M UAE cell and gene therapy spin-off amid major KEZAD expansion deal
The initiative will leverage the UAE–India healthcare corridor to expand access to gene therapies for high-need populations and strengthen cross-border biomedical collaboration.